UnitedHealth Stock (UNH) Tumbles 50% YTD; Here's How to Buy the Dip Without the Risk
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Let's take a deeper look at these two ETFs.
Harbor Health Care ETF
The MEDI ETF is an actively managed fund that targets long-term capital growth by investing in healthcare companies. The ETF provides exposure to UnitedHealth stock alongside other major players like Ascendis Pharma (ASND), Eli Lilly (LLY), and Legend Biotech (LEGN). Importantly, UNH accounts for 5.6% of the MEDI ETF's total holdings.
Overall, the ETF has $16.24 million in assets under management (AUM). Also, it has an expense ratio of 0.8%. Over the past three months, the MEDI ETF has generated a return of 5%.
On TipRanks, MEDI has a Strong Buy consensus rating based on 36 Buys and two Holds assigned in the last three months. At $37.67, the average MEDI ETF price target implies 42.79% upside potential.
T. Rowe Price Health Care ETF
The TMED ETF is an actively managed fund that aims to capture long-term growth opportunities in the healthcare sector, including pharmaceuticals, biotechnology, medical devices, and healthcare services.
UNH stock constitutes 5.91% of the ETF's holdings. Apart from UnitedHealth, some of the top stocks in the TMED ETF are AbbVie (ABBV), Abbott (ABT), and Danaher (DHR). Overall, the ETF has $11.81 million in AUM. Also, it has an expense ratio of 0.44%. The TMED ETF has declined 5.35% in the past three months.
Turning to Wall Street, the ETF has a Moderate Buy consensus rating. Of the 110 stocks held, 99 have Buys, 10 have Holds, and one Sell rating. At $33.65, the average TMED ETF price target implies a 41.31% upside potential.
Concluding Thoughts
ETFs provide indirect exposure to UNH stock, reducing risk compared to investing directly in the stock. Furthermore, ETFs are a liquid and transparent way to participate in the market. Investors seeking ETF recommendations might consider MEDI and TMED, as these ETFs offer exposure to UnitedHealth stock.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
19 minutes ago
- Business Insider
Is CSCO Stock a Buy? TipRanks AI Analyst Says Yes
Cisco Systems stock (CSCO) has earned an Outperform rating from TipRanks' A.I. Stock Analysis tool. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cisco attracts strong interest from investors and Wall Street analysts. Notably, TipRanks' A.I. Analyst also gave Cisco a positive rating, signaling confidence in the stock's potential. The tool assigns an Outperform rating on Cisco stock with a solid score of 78. Meanwhile, the A.I. analyst assigns a price target of $73 to CSCO stock, implying an upside of over 3% from the current levels. For context, TipRanks' A.I. Stock Analysis provides automated, data-backed evaluations of stocks across key metrics, offering users a clear and concise view of a stock's potential. CSCO's Financial Strength Our AI analyst states that Cisco Systems demonstrates robust financial performance with strong profitability and cash flow, underpinning its stability in the communication equipment industry. It explains that the positive momentum aligns well with strategic growth in AI infrastructure and partnerships. Indeed, Cisco is uniquely positioned to facilitate AI deployment with its networking and security portfolios, as well as Silicon One. In addition, product innovation is a strength with the company announcing noteworthy new offerings, including a Unified Cloud Management platform and Hybrid Mesh Firewall. Overall, our AI egghead believes that Cisco is well-positioned for growth, though investors should remain mindful of external challenges such as tariffs and sector-specific headwinds. However, as can be seen above it is not all good news for Cisco. There are macroeconomic risks and some uncertainty around the stock given its failure to disclose AI revenue numbers. There are also some technical and valuation concerns – as seen below. The technical indicators suggest caution due to potential overbought conditions. Valuation remains a concern due to a higher P/E ratio, yet the company's dividend yield adds some long-term investment appeal. What Other Analysts Say David Vogt of UBS raised the firm's price target on Cisco to $74 from $70 and kept a Neutral rating on the shares. He said that increasing campus and data center demand should drive a beat when it reports Q4 earnings this week. JPMorgan analyst Samik Chatterjee raised the firm's price target on Cisco to $78 from $73 and kept an Overweight rating on the shares. The firm adjusted price targets in hardware and networking, saying it expects upside to second half of 2025 estimates from 'robust' cloud spending. However, underlying end market drivers for other customer verticals 'remain a watchpoint' as they exhibit more sensitivity to the economic environment. Is CSCO a Good Stock to Buy Now?
Business Insider
19 minutes ago
- Business Insider
‘Time to Wave Bye Bye,' Says Former Bull About Palantir Stock
Palantir (NASDAQ:PLTR) stock has been the subject of a mad scramble in recent years, as investors rush to ride the big data company's momentum. Its Q2 2025 earnings release once again topped expectations, with revenues surpassing the $1 billion mark for the first time. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. That milestone reflects more than just solid sales figures – it underscores how Palantir has carved out a distinctive niche, offering platforms that empower sovereign actors and government clients to dramatically increase efficiency and make faster, better-informed decisions in real time. Capitalizing on these gains, the company has continued to raise guidance and secure major deals, the latest being a U.S. Army contract worth up to $10 billion over the next decade. With revenue growth seemingly on autopilot, it might appear there's little reason for long-term holders to waver. But not everyone is convinced. One investor, known by the pseudonym Weebler, just can't justify PLTR's valuation – despite being a fan of the company's incredibly impressive moat. 'Even when we hold an almost stubborn conviction in any company's long-term potential, we must strive to be willing to set aside personal bias when new variables shift the risk-reward equation,' admits the 5-star investor. For Weebler, the problem lies in what the market is currently pricing in. A forward P/E multiple near 420x is 'beyond excessive,' and even dialing that back to a lofty 60x assumes Palantir will grow earnings tenfold in just two years, a feat without precedent for a large-cap tech company. 'That is beyond what even the most elite, high-growth tech companies have historically achieved at this scale,' emphasizes Weebler, adding that such assumptions also hinge on the share price holding steady. While acknowledging that irrational exuberance could keep fueling the rally in the short term, Weebler has decided it's time to step aside, cutting his rating on PLTR from Buy to Sell. 'The market seems to be getting irrationally greedy, and the growth expectations have stepped beyond what the most hypergrowth plays have ever achieved,' the investor concludes. (To watch Weebler Finance's track record, click here) There is clearly an abundance of caution on Wall Street as well. With 13 Hold ratings far outweighing 5 Buys and 2 Sells, PLTR holds a consensus Hold (i.e. Neutral) rating. Its 12-month average price target of $154.56 implies a 17% downside from current levels. (See PLTR stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Business Insider
19 minutes ago
- Business Insider
'An Amazing Story': Intel Stock (NASDAQ:INTC) Jumps After Tan Meets With Trump
And just like that, things started looking up for chip stock Intel (INTC). You remember just yesterday, when CEO Lip-Bu Tan was under fire from President Trump, who called for his removal? Well, what started out as ' no other solution to the problem ' sure turned into an amazing story pretty quickly. In fact, that was exactly what President Trump had to say following his meeting with Lip-Bu Tan, and that was good enough for Intel investors. Intel investors sent shares climbing over 5% in Tuesday afternoon's trading. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Trump referred to Lip-Bu Tan as having an 'amazing story,' especially considering Tan's involvement in Walden International and Cadence Design Systems (CDNS). Tan, in a message to Intel employees, noted that there was 'misinformation' around his roles therein, and that he had '…always operated within the highest legal and ethical standards.' And Trump, perhaps understandably, was concerned about some of what had been going around about Tan's past involvement with companies, including some companies that later had connections to the People's Liberation Army in China. But those concerns seemed to go out the window as Trump later said, 'I met with Mr. Lip-Bu Tan, of Intel, along with Secretary of Commerce, Howard Lutnick, and Secretary of the Treasury, Scott Bessent. The meeting was a very interesting one. His success and rise is an amazing story. Mr. Tan and my Cabinet members are going to spend time together, and bring suggestions to me during the next week.' Speaking of Suggestions Based on what we have heard so far, the meetings between Trump and Tan may not be over, but rather, beginning. Trump noted that there would be further meetings, particularly between Tan and Trump's various cabinet members. Despite this, no one made any mention of just what Trump's cabinet would be talking to Lip-Bu Tan about in the next several days. There are certainly plenty of possible topics, ranging from CHIPS Act payments to tariffs on processors to even how to get Intel back up and running to the point where the United States has a major chipmaker in its arsenal again. Is Intel a Buy, Hold or Sell? Turning to Wall Street, analysts have a Hold consensus rating on INTC stock based on one Buy, 26 Holds and three Sells assigned in the past three months, as indicated by the graphic below. After a 0.88% rally in its share price over the past year, the average INTC price target of $22.10 per share implies 1.84% upside potential.
